
RxSight (RXST) Stock Forecast & Price Target
RxSight (RXST) Analyst Ratings
Bulls say
RxSight is supported by a differentiated light adjustable lens platform that continues to show pockets of strength through higher physician engagement and practice integration, while the Alcon collaboration underscores the value of its technology and could add $60M upfront plus up to $140M in milestones and royalties. Despite 3Q26 revenue missing consensus because of competitive pressures and restructuring-related disruption, gross margin remained strong at 73.6% and beat expectations, while operating expenses were about flat year over year at $36.6M, suggesting improving operating leverage. The investment case is strengthened by management’s shift toward increasing utilization across the installed base, more selective LDD placements, and a restructuring that is expected to lower 2027 opex, all of which support a path back to growth and improved cash burn.
Bears say
RxSight is facing deteriorating fundamentals as 3Q26 revenue fell 19% year over year to $24.6M, missing consensus on weaker LAL and LDD volumes, while adjusted EPS of -$0.21 and 73.6% gross margin showed both operating losses and margin compression from higher inventory costs and reserves. Competitive pressures, including trialing from a rival launch, and disruption from sales force reorganization have reduced utilization to 6.6 LALs per LDD, while the company also posted steep declines in LDD placements and warned that new LDD sales may remain nominal. The absence of FY guidance after withdrawal, elevated operating expenses of $36.6M, and uncertainty around execution during leadership and commercial strategy changes support a cautious outlook despite cash and restructuring efforts.
This aggregate rating is based on analysts' research of RxSight and is not a guaranteed prediction by Public.com or investment advice.
RxSight (RXST) Analyst Forecast & Price Prediction
Start investing in RxSight (RXST)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About RxSight (RXST) Forecast
RxSight (RXST) Analyst Forecast & Price Prediction
Start investing in RxSight (RXST)
Order type
Buy in
Order amount
Est. shares
0 shares